Clinical Trials · NCT02119819
A Study to Compare a New Drug for Type 2 Diabetes to Placebo and to a Treatment Already Available for Type 2 Diabetes
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- OPKO Health, Inc.
- Enrollment
- 420
- Start date
- Apr 2014
- Locations
- 51 sites, 6 countries
- Primary endpoint
- Change From Baseline in Hemoglobin A1c (HbA1c) at Week 12